Correlation of immunohistochemical markers and BRAF mutation status with histological variants of papillary thyroid carcinoma in the Korean population.
about
Tall cell variant of papillary thyroid carcinoma: current evidence on clinicopathologic features and molecular biologyClassic papillary thyroid carcinoma with tall cell features and tall cell variant have similar clinicopathologic features.BRAF mutation may predict higher necessity of postoperative radioactive iodine ablation in papillary thyroid cancerThe Frequency and Clinical Implications of the BRAF(V600E) Mutation in Papillary Thyroid Cancer Patients in Korea Over the Past Two Decades.The Warthin-Like Variant of Papillary Thyroid Carcinoma: A Comparison with Classic Type in the Patients with Coexisting Hashimoto's Thyroiditis.Comparison of the clinicopathological behavior of the follicular variant of papillary thyroid carcinoma and classical papillary thyroid carcinoma: A systematic review and meta-analysisPTEN loss is associated with follicular variant of Middle Eastern papillary thyroid carcinomaBRAF Testing in Multifocal Papillary Thyroid Carcinoma.A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis.Macrofollicular variant of papillary thyroid carcinoma with extensive lymph node metastases.Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".VE1 immunohistochemical detection of the BRAF V600E mutation in thyroid carcinoma: a review of its usefulness and limitations.Associations of the BRAF (V600E) mutation and p53 protein expression with clinicopathological features of papillary thyroid carcinomas patients.Follicular variant of papillary thyroid carcinoma (FVPTC): histological features, BRAF V600E mutation, and lymph node status.Prevalence of BRAFV600E Mutation in Follicular Variant of Papillary Thyroid Carcinoma and Non-Invasive Follicular Tumor with Papillary-Like Nuclear Features (NIFTP) in a BRAFV600E Prevalent Area.
P2860
Q28078437-054E4450-CA46-4796-88AC-45F194D9BCD3Q33864968-4AA54D20-A5CE-4332-87B4-AFE076BAFF56Q34335766-6B995AE8-1452-4A1E-8E1F-7C9B6175ED53Q34839781-45A9CA0E-4818-4E6C-97F8-39020E0BA227Q35578725-2D879B89-F99F-42DB-B212-760AF3D13290Q35803487-0525C45D-28B6-4702-8ECF-E23369688CCBQ36086862-9798172D-48C1-422F-9C4C-ABE6416E99B8Q36095556-1542FACB-5E1D-4657-8DAA-24E4FD015005Q37701580-B9DE1E94-5E46-4381-92AC-4771A9D1A31EQ38199653-618FF8D1-1316-4621-86D3-B1D0131EC71CQ38225733-314EC2E3-873E-4707-AFB0-E8670EFBC12AQ38426776-E58F1AFC-A00F-4111-82AA-B56D2417F77DQ42456317-D54CC21F-EA5B-44F4-85A3-2DE60B4884CBQ53601990-7A30B033-4934-4D8B-AD77-1140FD8CF494Q55394993-AC0BBE36-1A09-45B7-A05D-3531C59EA3A6
P2860
Correlation of immunohistochemical markers and BRAF mutation status with histological variants of papillary thyroid carcinoma in the Korean population.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Correlation of immunohistochem ...... noma in the Korean population.
@ast
Correlation of immunohistochem ...... noma in the Korean population.
@en
type
label
Correlation of immunohistochem ...... noma in the Korean population.
@ast
Correlation of immunohistochem ...... noma in the Korean population.
@en
prefLabel
Correlation of immunohistochem ...... noma in the Korean population.
@ast
Correlation of immunohistochem ...... noma in the Korean population.
@en
P2093
P2860
P1476
Correlation of immunohistochem ...... noma in the Korean population.
@en
P2093
Hye Sook Min
Kyeong Cheon Jung
P2860
P304
P356
10.3346/JKMS.2013.28.4.534
P577
2013-03-27T00:00:00Z